SE440647B - Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol - Google Patents

Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol

Info

Publication number
SE440647B
SE440647B SE7702251A SE7702251A SE440647B SE 440647 B SE440647 B SE 440647B SE 7702251 A SE7702251 A SE 7702251A SE 7702251 A SE7702251 A SE 7702251A SE 440647 B SE440647 B SE 440647B
Authority
SE
Sweden
Prior art keywords
dichlorphenoxy
butylamino
propanol
tert
prepare
Prior art date
Application number
SE7702251A
Other languages
English (en)
Other versions
SE7702251L (sv
Inventor
A Hajos
M Fekete
M Kurti
T Lang
L Toldy
J Borvendeg
L Nagy
S Elek
I Polgari
I Elekes
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE7702251L publication Critical patent/SE7702251L/sv
Publication of SE440647B publication Critical patent/SE440647B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7702251A 1976-03-02 1977-03-01 Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol SE440647B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (2)

Publication Number Publication Date
SE7702251L SE7702251L (sv) 1977-09-03
SE440647B true SE440647B (sv) 1985-08-12

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702251A SE440647B (sv) 1976-03-02 1977-03-01 Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol

Country Status (25)

Country Link
US (1) US4310549A (sv)
JP (1) JPS5923299B2 (sv)
AT (1) AT348507B (sv)
AU (1) AU508766B2 (sv)
BE (1) BE851938A (sv)
CA (1) CA1091254A (sv)
CH (1) CH627732A5 (sv)
CS (1) CS190340B2 (sv)
DD (1) DD128610A5 (sv)
DE (1) DE2709109C3 (sv)
DK (1) DK143554C (sv)
FI (1) FI65231C (sv)
FR (1) FR2342956A1 (sv)
GB (1) GB1573191A (sv)
HU (1) HU172137B (sv)
IL (1) IL51574A (sv)
IN (1) IN144243B (sv)
KE (1) KE3340A (sv)
MY (1) MY8500104A (sv)
NL (1) NL7702170A (sv)
NO (1) NO141989C (sv)
PL (1) PL103734B1 (sv)
SE (1) SE440647B (sv)
SU (1) SU648080A3 (sv)
YU (1) YU40813B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (sv) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
IL51574A0 (en) 1977-05-31
GB1573191A (en) 1980-08-20
HU172137B (hu) 1978-06-28
PL103734B1 (pl) 1979-07-31
ATA134177A (de) 1978-07-15
DK143554B (da) 1981-09-07
FI65231C (fi) 1984-04-10
YU40813B (en) 1986-06-30
AU508766B2 (en) 1980-04-03
FI770651A (sv) 1977-09-03
SE7702251L (sv) 1977-09-03
NO770688L (no) 1977-09-05
NO141989C (no) 1980-06-11
CA1091254A (en) 1980-12-09
DE2709109A1 (de) 1977-09-15
NO141989B (no) 1980-03-03
US4310549A (en) 1982-01-12
AT348507B (de) 1979-02-26
IN144243B (sv) 1978-04-15
YU54977A (en) 1982-10-31
DD128610A5 (de) 1977-11-30
MY8500104A (en) 1985-12-31
FI65231B (fi) 1983-12-30
KE3340A (en) 1983-11-25
DK143554C (da) 1982-03-08
IL51574A (en) 1980-01-31
FR2342956B1 (sv) 1982-11-26
CH627732A5 (de) 1982-01-29
FR2342956A1 (fr) 1977-09-30
CS190340B2 (en) 1979-05-31
SU648080A3 (ru) 1979-02-15
DE2709109B2 (de) 1980-01-17
DK88577A (da) 1977-09-03
JPS52122328A (en) 1977-10-14
JPS5923299B2 (ja) 1984-06-01
DE2709109C3 (de) 1980-09-18
AU2279577A (en) 1978-09-07
BE851938A (fr) 1977-09-01
NL7702170A (nl) 1977-09-06

Similar Documents

Publication Publication Date Title
NL7901842A (nl) Beademingsapparaat.
NL184309C (nl) Beademingstoestel.
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
NL7902881A (nl) Ritssluiting.
NL7614054A (nl) Betainen.
SE441042B (sv) Sett att pavisa rheumatoida faktorer
NL7901196A (nl) Ritssluiting.
SE432256B (sv) Sett att framstella cellulosaalkyletrar
NL7706260A (nl) Spatel.
FI793663A (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE430687B (sv) Sett att framstella hexanitrostilben
SE7803411L (sv) 2,6-dialkoxibensamider
NL7902598A (nl) Ritssluiting.
NL183270C (nl) Ritssluiting.
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE425321B (sv) Sett att reducera vanadinoxider
PT66492B (de) 1,3-dihydro-heteroarylspiro/isobenzofuran/s
BE856409A (fr) 2,6-methano-2h-1-benzoxocines
BE854184A (fr) 1,2,6-thiadiazinones
FI773466A (fi) Substituerade 2,1,3-bentsotiadiazinfoereningar
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE440647B (sv) Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
SE417719B (sv) Sett att framstella 2,2-dimetyl-19-nor-steroider tillhorande pregnanserien
SE7513235L (sv) Sett att framstella 1,4-bensodioxaner.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7702251-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7702251-5

Format of ref document f/p: F